Ashton Thomas Securities LLC Increases Position in Smith & Nephew SNATS, Inc. $SNN

Key Points

• Ashton Thomas Securities LLC increased its stake in Smith & Nephew SNATS, Inc. by 43.1%, owning 55,402 shares, valued at approximately $1.57 million following the purchase of an additional 16,692 shares in Q1.
• Several other institutional investors have made significant adjustments to their positions in Smith & Nephew, including Bessemer Group Inc., which raised its stake by 3,471.4%, bringing total institutional ownership to 25.64% of the company's stock.
• Smith & Nephew recently declared a semi-annual dividend of $0.285 per share with a yield of 210.0%, while analysts maintain a consensus rating of "Hold" with a target price of $36.00.

Ashton Thomas Securities LLC increased its holdings in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) by 43.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 55,402 shares of the medical equipment provider's stock after acquiring an additional 16,692 shares during the period. Ashton Thomas Securities LLC's holdings in Smith & Nephew SNATS were worth $1,572,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Hexagon Capital Partners LLC boosted its holdings in Smith & Nephew SNATS by 63.3% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock worth $30,000 after buying an additional 406 shares during the last quarter. Richards Merrill & Peterson Inc. boosted its holdings in Smith & Nephew SNATS by 500.0% in the 1st quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock worth $34,000 after buying an additional 1,000 shares during the last quarter. Bessemer Group Inc. boosted its holdings in Smith & Nephew SNATS by 3,471.4% in the 1st quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock worth $49,000 after buying an additional 1,701 shares during the last quarter. Hara Capital LLC boosted its holdings in Smith & Nephew SNATS by 391.4% in the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after buying an additional 1,957 shares during the last quarter. Finally, Opal Wealth Advisors LLC acquired a new stake in Smith & Nephew SNATS in the 1st quarter worth about $73,000. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Wall Street Zen upgraded Smith & Nephew SNATS from a "buy" rating to a "strong-buy" rating in a report on Saturday. Canaccord Genuity Group lifted their price objective on Smith & Nephew SNATS from $28.00 to $36.00 and gave the stock a "hold" rating in a report on Monday, August 18th. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $36.00.

Smith & Nephew SNATS Price Performance

Shares of Smith & Nephew SNATS stock traded up $0.46 on Wednesday, hitting $37.36. 538,338 shares of the company were exchanged, compared to its average volume of 837,086. The stock has a market capitalization of $16.36 billion, a price-to-earnings ratio of 17.30, a price-to-earnings-growth ratio of 1.03 and a beta of 0.71. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $33.27 and a 200 day moving average price of $29.88. Smith & Nephew SNATS, Inc. has a 1-year low of $23.69 and a 1-year high of $37.65.

Smith & Nephew SNATS Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be given a dividend of $0.285 per share. This represents a dividend yield of 210.0%. The ex-dividend date of this dividend is Friday, October 3rd. Smith & Nephew SNATS's payout ratio is presently 41.20%.

Smith & Nephew SNATS Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.